Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Syngenis joins WA research heavyweights in RNA medicine push

Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

First reported by The Age Latest report 2 sources
Image: The Age
Image: The Age
Read at The Sydney Morning Herald(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. The Age

    Syngenis joins WA research heavyweights in RNA medicine push (opens The Age in a new tab)

    Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

  2. The Sydney Morning Herald

    Syngenis joins WA research heavyweights in RNA medicine push (opens The Sydney Morning Herald in a new tab)

    Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

Something wrong with how we've grouped or summarised this story? Report a problem